norelgestromin

Known as: 17-deacetylnorgestimate, norelgestromin [Chemical/Ingredient], Norplant 3-oxime 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2017
024619992017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
OBJECTIVE To compare the effects of continuous use of oral (OC), transdermal, and vaginal combined contraceptives on the… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
BACKGROUND Acne occurs from an overstimulation of the sebaceous glands by high levels of androgens or because sebaceous glands… (More)
Is this relevant?
2007
2007
CONTEXT In 2006, we published a study that indicated that the new transdermal contraceptive patch containing ethinyl estradiol… (More)
Is this relevant?
2005
2005
OBJECTIVE To compare bleeding profiles and satisfaction among women using a norelgestromin/ethinyl estradiol (E2) transdermal… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2003
2003
OBJECTIVE To evaluate the metabolic impact on lipids of a contraceptive patch that delivers norelgestromin (primary active… (More)
Is this relevant?
2002
2002
AIMS To determine the pharmacokinetic profile of norelgestromin (NGMN) and ethinyloestradiol (EE) following application of the… (More)
Is this relevant?
2002
2002
OBJECTIVE The objective of this study was to identify the dose for a contraceptive patch that provides a predetermined level of… (More)
Is this relevant?
2001
2001
The primary objective of this open-label study was to determine the pharmacokinetics of norelgestromin (NGMN) and ethinyl… (More)
Is this relevant?
2001
2001
The objectives of this randomized, open-label, three-period, incomplete block design study were to evaluate the pharmacokinetics… (More)
Is this relevant?